Regulatory Updates- Feb 2019
US FDA: CDRH Fleshes Out Guidance on Application of Least Burdensome Provisions Read more… Dissolution Testing: British Pharmacopoeia Responds to
US FDA: CDRH Fleshes Out Guidance on Application of Least Burdensome Provisions Read more… Dissolution Testing: British Pharmacopoeia Responds to